Atlanta Consulting Group Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Atlanta Consulting Group Advisors's BMY Position: Q4 2024 in Review
Atlanta Consulting Group Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 23,252 shares — an estimated $1.2M sold.
Atlanta Consulting Group Advisors first reported a position in BMY in Q3 2024 and held it in 1 quarter. The position peaked at $1.2M in Q3 2024. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Atlanta Consulting Group Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
- Atlanta Consulting Group Advisors sold 23,252 Bristol-Myers Squibb shares in Q4 2024, an estimated $1.2M.
- Atlanta Consulting Group Advisors first reported a position in Bristol-Myers Squibb in Q3 2024 and held it in 1 quarter.
- Atlanta Consulting Group Advisors's Bristol-Myers Squibb position peaked at $1.2M in Q3 2024.
- 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Atlanta Consulting Group Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.